Ige Anti-Fcεri Antibodies In Chronic Spontaneous Urticaria

Anti-Myc and Anti-DDK monoclonal antibodies
TA150014 2 tubes @ 50 ul each Ask for price

Ige Antibody Laboratories manufactures the ige anti-fcεri antibodies in chronic spontaneous urticaria reagents distributed by Genprice. The Ige Anti-Fcεri Antibodies In Chronic Spontaneous Urticaria reagent is RUO (Research Use Only) to test human serum or cell culture lab samples. To purchase these products, for the MSDS, Data Sheet, protocol, storage conditions/temperature or for the concentration, please contact ige antibody. Other Ige products are available in stock. Specificity: Ige Category: Anti-Fcεri Group: Antibodies In

True Blue
50mg Ask for price
  • SMILES: N=C(C1=CC=C(OC(/C=C/C2=CC3=CC(C(N)=N)=CC=C3O2)=C4)C4=C1)N.Cl.Cl
  • Formula: C20H18Cl2N4O2
Description: True Blue

True Blue
5mg Ask for price
  • SMILES: N=C(C1=CC=C(OC(/C=C/C2=CC3=CC(C(N)=N)=CC=C3O2)=C4)C4=C1)N.Cl.Cl
  • Formula: C20H18Cl2N4O2
Description: True Blue

True Blue
5(mg
EUR 635

True Blue
5x5(mg
EUR 2705

Set of 10 plant anti-Lhca and anti-Lhcb antibodies
0.5 mg
EUR 1942

JBS True Blue
300µl
EUR 13.7

True Blue Chloride
100mg
EUR 11200
  • C₂₀H₁₆N₄O₂ • 2HCl
Description: 71431-30-6

Antibodies In information

Recombinant Hordeum vulgare subsp. spontaneum Beta-amylase (BMY1)
MBS1253633-01mgYeast 0.1mg(Yeast)
EUR 1305

Recombinant Hordeum vulgare subsp. spontaneum Maturase K (matK), partial
MBS1447280-INQUIRE INQUIRE Ask for price

Human Chronic Myeloid Leukemia Bone Marrow Plasma (Chronic Phase)
ABC-TC3361 1 vial Ask for price
  • For research use only
Description: Chronic Myeloid Leukemia-Bone Marrow plasma is obtained by centrifugation of the Chronic Myeloid Leukemia bone marrow. Plasma has a diminished number of cells and platelets. Chronic Myeloid Leukemia-Bone Marrow plasma is available in chronic phase and accelerated or blast crisis phase.

Human Chronic Myeloid Leukemia Bone Marrow CD34+ Cells(Chronic Phase)
ABC-TC3357 1 vial Ask for price
  • For research use only
Description: Chronic Myeloid Leukemia-Bone Marrow-CD34+ Cells are isolated from the bone marrow using a direct CD34 MicroBead labeling system. Chronic Myeloid Leukemia-Bone Marrow-CD34+ Cells are available in the chronic phase and the acceleration or blast crisis phase.

Recombinant Saccharum spontaneum Cytochrome b6-f complex subunit 6 (petL), partial
MBS7083097-INQUIRE INQUIRE Ask for price

Human Chronic Myeloid Leukemia Bone Marrow Mononuclear Cells (Chronic Phase)
ABC-TC3359 1 vial Ask for price
  • For research use only
Description: Chronic Myeloid Leukemia-Bone Marrow-Mononuclear Cells are isolated by diluting Chronic Myeloid Leukemia bone marrow with phosphate-buffered saline and using gradient separation techniques. After centrifugation, the Mononuclear Cells layer is collected. Chronic Myeloid LeukemiaMononuclear Cells can be processed further to isolate subpopulations. Chronic Myeloid Leukemia-Bone MarrowMononuclear Cells are available in either the chronic phase or accelerated/blast crisis phase.

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC802035-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC802035-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC802046-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC802046-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680 conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC812035-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC812035-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC812046-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC812046-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF680R conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC052035-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035) Antibody
BNC052035-500 500uL
EUR 654
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2035), CF405M conjugate, Concentration: 0.1mg/mL

ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046) Antibody
BNC052046-100 100uL
EUR 279.6
Description: Primary antibody against ZAP70 (Chronic Lymphocytic Leukemia Marker) (ZAP70/2046), CF405M conjugate, Concentration: 0.1mg/mL